Certara to Participate in Upcoming Investor Conferences
Certara (Nasdaq: CERT), a global leader in model-informed drug development, has announced its participation in two upcoming investor conferences in September 2025.
Management will present at the Baird Global Healthcare Conference on Tuesday, September 9 at 10:15 a.m. ET, followed by the Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10 at 12:20 p.m. ET. Both presentations will be available via webcast on Certara's investor relations website with replay access for 90 days.
Certara (Nasdaq: CERT), leader globale nello sviluppo di farmaci basato su modelli, ha annunciato la propria partecipazione a due conferenze per investitori previste per settembre 2025.
La direzione terrà una presentazione al Baird Global Healthcare Conference martedì 9 settembre alle 10:15 ET, seguita dalla presentazione al Morgan Stanley 23rd Annual Global Healthcare Conference mercoledì 10 settembre alle 12:20 ET. Entrambe le presentazioni saranno trasmesse in webcast sul sito investor relations di Certara e saranno disponibili in replica per 90 giorni.
Certara (Nasdaq: CERT), líder mundial en desarrollo de fármacos guiado por modelos, ha anunciado su participación en dos próximas conferencias para inversores en septiembre de 2025.
La dirección presentará en el Baird Global Healthcare Conference el martes 9 de septiembre a las 10:15 a.m. ET, seguido por el Morgan Stanley 23rd Annual Global Healthcare Conference el miércoles 10 de septiembre a las 12:20 p.m. ET. Ambas presentaciones estarán disponibles vía webcast en la página de relaciones con inversores de Certara y podrán verse en reproducción durante 90 días.
Certara (Nasdaq: CERT), 모델 기반 의약품 개발의 글로벌 리더인 기업이 2025년 9월에 열리는 두 건의 투자자 콘퍼런스에 참가한다고 발표했습니다.
경영진은 9월 9일 화요일 오전 10시 15분(동부시간)에 열리는 Baird Global Healthcare Conference에서 발표하고, 이어 9월 10일 수요일 오후 12시 20분(동부시간)에 열리는 Morgan Stanley 23rd Annual Global Healthcare Conference에서 발표할 예정입니다. 두 발표 모두 Certara 투자자 관계 웹사이트를 통해 웹캐스트로 제공되며, 90일간 다시보기 서비스를 이용할 수 있습니다.
Certara (Nasdaq: CERT), leader mondial du développement de médicaments fondé sur la modélisation, a annoncé sa participation à deux conférences investisseurs prévues en septembre 2025.
La direction présentera au Baird Global Healthcare Conference le mardi 9 septembre à 10h15 ET, puis au Morgan Stanley 23rd Annual Global Healthcare Conference le mercredi 10 septembre à 12h20 ET. Les deux présentations seront diffusées en webcast sur le site des relations investisseurs de Certara et resteront disponibles en replay pendant 90 jours.
Certara (Nasdaq: CERT), ein weltweit führendes Unternehmen für modellgestützte Arzneimittelentwicklung, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im September 2025 angekündigt.
Das Management wird am Baird Global Healthcare Conference am Dienstag, den 9. September um 10:15 Uhr ET präsentieren, gefolgt vom Morgan Stanley 23rd Annual Global Healthcare Conference am Mittwoch, den 10. September um 12:20 Uhr ET. Beide Präsentationen werden als Webcast auf Certaras Investor-Relations-Website verfügbar sein und können für 90 Tage als Aufzeichnung abgerufen werden.
- None.
- None.
RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:
- Baird Global Healthcare Conference
Date and Time: Tuesday, September 9 at 10:15 a.m. ET
- Morgan Stanley 23rd Annual Global Healthcare Conference
Date and Time: Wednesday, September 10 at 12:20 p.m. ET
Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.
About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Alyssa Horowitz
certara@pancomm.com
FAQ
When is Certara (CERT) presenting at the Baird Global Healthcare Conference 2025?
What time is Certara's presentation at the Morgan Stanley Healthcare Conference 2025?
How can investors access Certara's conference presentations in September 2025?
Which investor conferences is Certara (CERT) attending in September 2025?
